Clinical Trial Update: Tolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell). [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on tolerability, safety, and immunogenicity of a tetravalent inactivated enterovirus vaccine (Vero cell) for Hand, Foot, and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Foot and Mouth Disease
• Herpangina

Drugs mentioned

• Tetravalent Inactivated Enterovirus Vaccine (Vero Cell) (tetravalent inactivated enterovirus vaccine)

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Hand, Foot, and Mouth Disease (HFMD), Herpangina | Phase 1, Phase 2 | Status: COMPLETED